SciSparc Ltd. (NASDAQ:SPRC – Get Free Report)’s stock price was down 0.1% on Monday . The stock traded as low as $0.6406 and last traded at $0.6832. Approximately 93,964 shares traded hands during mid-day trading, a decline of 96% from the average daily volume of 2,457,542 shares. The stock had previously closed at $0.6840.
SciSparc Stock Performance
The firm’s 50 day moving average is $1.31 and its 200-day moving average is $2.94.
SciSparc (NASDAQ:SPRC – Get Free Report) last released its earnings results on Tuesday, November 18th. The company reported ($3.08) earnings per share for the quarter. The business had revenue of $0.23 million for the quarter.
About SciSparc
SciSparc AG is a clinical‐stage medical technology company focused on the development and commercialization of extracorporeal shock wave–based neuromodulation devices. Founded in 2016 and headquartered in Switzerland, the company applies proprietary low‐intensity shock wave technology to noninvasively stimulate neural tissue. SciSparc completed its initial public offering on the NASDAQ in 2021 under the ticker SPRC, securing funding to advance its clinical pipeline.
The company’s lead product, the TR100 system, delivers transcranial shock wave stimulation (tSWS) designed to target areas of the brain associated with motor control and cognitive function.
Recommended Stories
- Five stocks we like better than SciSparc
- The buying spree that no one is talking about
- How to collect $500-$800 weekly (BlackRock’s system)
- Trump’s AI Secret: 100X Faster Than Nvidia
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
Receive News & Ratings for SciSparc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SciSparc and related companies with MarketBeat.com's FREE daily email newsletter.
